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Background/aim: We aimed to analyze the value of 3 serial sections, spaced 200 µm apart, for quantification of lymphocyte and plasma
cell foci in minor salivary gland biopsy (MSGB).
Materials and methods: Labial MSGBs from 69 patients with Sjögren’s syndrome (SS) and scleroderma were used for this study. Each
sample was prepared as 3 serial sections spaced 200 µm apart. Lymphocytic and plasma cell focus score (LFS, PFS) were determined for
each section, and the diagnostic results were compared to those obtained from a single section.
Results: For 22 of the 69 patients, all 3 sections were scored at <1 and interpreted as inconclusive for the presence of SS. For 20 cases,
all 3 sections were scored at ≥1 and interpreted as diagnostic for SS. In the remaining 27 cases, the score was found to vary between
sections. Plasma cell foci were observed in 11 cases, with 5 cases exhibiting a PFS of ≥1. Of those 5 cases, 4 also had a LFS of ≥1.
Conclusion: Assessment of 3 serial sections in MSGB has the potential to improve accuracy of SS diagnosis by detecting specific features
that may not have been detected in a single section. We concluded that data about the PFS require further evaluation.
Key words: Sjögren’s syndrome, focus score, multilevel examination

1. Introduction
Sjögren’s syndrome (SS) is a chronic inflammatory disorder
of exocrine glands that clinically presents as ‘sicca syndrome’.
Inflammation with specific features observed on labial
minor salivary gland biopsy (MSGB) is considered to be
one of the ‘gold-standard’ criteria for the diagnosis of SS
(1). However, the distribution of the inflammatory cells in
the gland may be uneven. It has previously been suggested
that, considering this uneven distribution, a single
tissue section may result in underdiagnosis. While other
investigators have attempted to address this possibility,
a conclusive answer has not been found, and the topic
remains a source of some controversy (2). In this series, we
aimed to analyze the diagnostic impact of examination of
MSGB at 3 serial levels and compare that to the diagnostic
impact of examination at a single level.
2. Materials and methods
MSGBs of 69 patients with a documented history of
xerostomia and/or xerophthalmia complaints, as well as
clinical suspicion of SS, were evaluated retrospectively.
All patients had presented to a rheumatology clinic for
follow-up appointments. Biopsies were performed in
* Correspondence: kucukulku@hotmail.com

order to determine if these patients met the criteria for SS
diagnosis. The evaluation was performed using only biopsy
results, with no consideration of American-European
Consensus Group (AECG) criteria or serological markers.
For routine histopathological evaluation, MSGB
sections were fixed in 10% formalin and embedded in
paraffin. Tissue was sectioned at 3 levels spaced 200 µm apart.
All samples were stained with hematoxylin and eosin.
The tissue sections were reevaluated separately in
order to detect both lymphocyte and plasma cell foci. A
lymphocytic focus was defined as an accumulation of ≥50
lymphocytes (3). The focus score (FS) was classified as: FS
0, no lymphocytic infiltration; FS 1, slight lymphocytic
infiltrate; FS 2, less than 1 lymphocytic foci per 4 mm2;
FS 3, 1 lymphocytic foci per 4 mm2; FS 4, more than 1
lymphocytic foci per 4 mm2 (4). Plasma cell focus was
defined as the accumulation of ≥20 plasma cells; plasma
cell FS was determined similarly to the lymphocytic FS.
The lymphocytic and plasmacytic foci were counted under
light microscopy. The surface area of the MSGB section
was determined by point-counting with a grid overlying
the tissue section.

63

SARIOĞLU et al. / Turk J Med Sci
Focus scores for plasma cell and lymphocytic foci
were determined for each section. A focus score of ≥1 was
accepted as diagnostic for SS. Once focus scores had been
determined for all sections, the 3 focus scores for each
patient were compared to each other to detect variation
between sections.
3. Results
The mean age of the patients was 51.9 years (min: 22,
max: 79), including 60 (87%) females and 9 (13%)
males. Of 69 patients, 35 (50.72%) had primary SS, 22
(31.88%) had scleroderma + SS, and 12 (17.39%) had
scleroderma. Distributions of sex and final diagnosis are
shown in the Table. If the highest FS among the 3 sections
is considered, FS was less than 1 in 37 cases (53.6%) and
higher than 1 in 32 cases (46.4%).
For 22 of the 69 patients, all 3 sections were scored at
<1, interpreted as inconclusive for the presence of SS. For
20 cases, all 3 sections were scored at ≥1, interpreted as
diagnostic for SS. In the remaining 27 cases, the score was
found to vary between sections. Had only a single section
been used for evaluation, these 27 cases (39.1% of the
total) may have erroneously been found inconclusive for a
diagnosis of SS (Figure 1).
Plasma cell foci were observed in 11 cases, and 5 (7.2%)
cases had plasma cell FS of ≥1. Four of these 5 cases were also
found to have a lymphocytic FS higher than 1 (Figure 2).

4. Discussion
SS is characterized by diffuse chronic inflammation of
the exocrine glands. The disease most frequently affects
middle-aged women with a sex ratio of 10:1 (1). The
diagnosis is based on the evaluation of multiple clinical,
serological, functional, and morphological parameters (5).
Characteristic patterns of inflammation observed
on labial MSGB is considered one of the ‘goldstandard’ criteria for diagnosis of SS (1). Salivary gland
inflammation is assessed by scoring the degree of
infiltration. The histopathological diagnostic criterion for
SS is >50 lymphocytes per 4 mm2 of minor salivary gland
tissue (FS ≥ 1) (4,6).
As inflammatory cells in the gland may be
unevenly distributed, the examination of a single tissue
section may underestimate the FS (2). While increasing
the number of sections has the potential to reduce this
problem, the optimal number of sections has yet to be
determined (8). Studies dealing with this issue are still
limited, and what results do exist remain controversial.
Al-Hashimi et al. (1) reported that the measured FS can
change significantly at different tissue depths within the
minor salivary glands. They analyzed 38 MSGBs, which
were examined at 6 different tissue depths (6 µm, 50 µm,
100 µm, 150 µm, 200 µm, 250 µm). In their study, the majority
of the biopsies were found to exhibit substantial variability
at all depths. The differences observed were sufficient to
affect the diagnosis in approximately 60% of the biopsies.

Table. Distribution of sex and final diagnosis of patients.
Patients

n (%)

Primary SS (%)

Scleroderma + SS (%)

Scleroderma (%)

Female

60 (87%)

31 (51.7%)

19 (31.7%)

10 (16.7%)

Male

9 (13%)

4 (44.4%)

3 (33.3%)

2 (22.2)

Figure 1. Lymphocytic foci around salivary duct (H&E, 200×).
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Figure 2. Plasma cell foci at the salivary gland stroma (H&E,
200×).
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Morbini et al. (2) also analyzed 120 MSGBs, cut into
3 sections at 200-µm intervals. When multiple sections
were taken, the diagnostic classification changed in
6% of the cases. They subsequently divided the cases
into 2 groups: cases with a FS of ≥1 and <2, and cases
with FS of ≥2. Taking multiple sections was also shown
to increase the specificity of MSGB for the first group,
whereas the increase was minimal in the second
group (2). When patients were classified according to
the AECG criteria, the specificity of MSGB evaluation
increased by 9.8%, with a statistically significant
improvement observed in the diagnostic performance of
MSGB.
Contrary to these results, Scardina et al. (8) analyzed
24 labial MSGBs, also sectioned at 3 levels 200 µm apart.
In their study, they observed no significant variation in
FS distribution between the 3 serial sections.
In our study, a category discrepancy between different
sections was observed in 27 (39.1%) cases. These cases
represent a significant portion of all the cases examined
and could have been misdiagnosed if only a single section
was examined.
Although plasma cells may be found in salivary glands,
there is insufficient data to determine the diagnostic
significance of an elevated number of plasma cells
in MSGB. Antibodies secreted by plasma cells can mediate
protection against many microorganisms, as well as
contribute to the pathogenesis of autoimmune diseases
(9). Autoantibodies can persist for years in patients with
autoimmune diseases such as SS. The aim of the treatment of

autoimmune conditions should be to prevent the initiation
of immune responses without affecting noncycling
memory and the long-lived plasma cells formed long before
treatment (10). Recently, Szyszko et al. (11) evaluated the
presence of plasma cells residing in the salivary glands
of primary SS patients with high FS and found that these
cells showed phenotypic characteristics of the long-lived
plasma cell subtype. However, they did not evaluate the
diagnostic value of plasma cell foci in MSGB.
In our study, plasma cell FS was defined as the
accumulation of 20 plasma cells, and this was equal to
plasma cell FS of 1 if only one focus was observed in 4
mm2 of tissue. We observed ≥1 plasma cell FS in 5 (7.2%)
cases; of these, 4 cases had a lymphocytic FS higher than
1, sufficient to diagnose SS without any consideration of
plasma cells. Considering that only one case was found
to have a plasma cell FS of ≥1 with a lymphocytic FS of
<1, it is difficult to evaluate the utility of plasma cell foci
in diagnosing SS. A larger study with more patients may
allow for a more thorough evaluation.
In conclusion, our study suggests that the assessment
of an FS obtained for each of the 3 serial sections at a
distance of 200 µm increases the diagnostic usefulness
of labial MSGBs. We concur with the previous
recommendations of Al-Hashimi et al. (1) and Morbini et
al. (2), who suggested that multiple sections for labial
MSGB should be used in daily practice. We also provided
data that suggest that the diagnostic utility of plasma cell
foci in labial MSGB requires further evaluation.
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